Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 44,707 | 39,570 | 43,771 | 40,706 | 41,337 |
| Cost of Goods | 979 | 1,017 | 1,603 | 1,133 | 1,178 |
| Gross Profit | 43,728 | 38,553 | 42,168 | 39,573 | 40,159 |
| Operating Expenses | 81,236 | 76,798 | 47,756 | 75,289 | 61,897 |
| Operating Income | -36,529 | -38,228 | -4,985 | -35,583 | -21,560 |
| Interest Expense | 4,817 | 4,865 | 5,065 | 2,533 | 1,057 |
| Other Income | 2,714 | 2,517 | 2,595 | -15,985 | 455 |
| Pre-tax Income | -38,632 | -40,576 | -7,455 | -54,101 | -22,162 |
| Income Tax | 69 | 401 | N/A | 415 | 167 |
| Net Income Continuous | -38,701 | -40,977 | -7,455 | -54,516 | -22,329 |
| Net Income | $-38,701 | $-40,977 | $-7,455 | $-54,516 | $-22,329 |
| EPS Basic Total Ops | -0.92 | -0.99 | -0.18 | -1.34 | -0.56 |
| EPS Basic Continuous Ops | -0.92 | -0.99 | -0.18 | -1.34 | -0.56 |
| EPS Diluted Total Ops | -0.92 | -0.99 | -0.18 | -1.34 | -0.56 |
| EPS Diluted Continuous Ops | -0.92 | -0.99 | -0.18 | -1.34 | -0.56 |
| EBITDA(a) | $-54,951 | $-5,711 | $1,945 | $-30,028 | $-16,301 |